Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Share This Webinar
About This Webinar
As the industry quickly evolves, we offer technology that robustly scales from the laboratory and is proven to work in industrial processes to reduce your technology transfer risks. Whether you prefer an end to end, integrated platform to reduce development time or just one technology, we have the products, knowledge and services to help you deliver your gene therapy to market.
Language:
English
Who can attend? Everyone
Featured Presenters
Dr Clive Glover is the Director of Cell & Gene Therapy at Pall Biotech. Clive leads Pall’s cell and gene therapy business. He has over 15 years of experience in cell and gene therapy. His work has been published in numerous scientific journals, and he has presented at many conferences.
Dr Rachel Legmann is the senior lab manager leading Pall’s Westborough end-to-end process development services (PDS) and collaboration laboratory. She is responsible for scale-up, continuous bioprocessing and manufacturing support activities for gene therapy and biologic markets.
Hosted By
The full session archive, available exclusively for attendees of the American Society of Gene & Cell Therapy's 23rd Annual Meeting, May 12-15, 2020.
Documents